Clinico-microbiological Profile of Nontuberculous Mycobacterial Keratitis


Purpose: To assess the clinical and microbiological characteristics of nontuberculous mycobacterial (NTM) keratitis and to evaluate their response to medical therapy.

Methods: Sixteen patients of NTM keratitis were retrospectively reviewed from May 2014 to May 2019. Laboratory diagnosis were made using Ziehl-Nielsen acidfast staining, routine culture method of isolation of nontuberculous mycobacteria and further identification of species by PCR (polymerase chain reaction)-based DNA sequencing targeting the heat shock protein-65 (hsp-65) gene.

Results: Sixteen patients of microbiologically proven NTM keratitis were included. The average age at the time of presentation was 43.56 years (range, 24–73 years). The mean duration of symptoms was 2.23 months. The commonest risk factor was injury with organic material (43.7) followed by ocular surgery (25%). The majority of the nontuberculous mycobacteria were Mycobacterium abscessus (87.6%) followed by M. fortuitum (6.2%) and M. chelonae (6.2%). The in vitro sensitivity showed maximum sensitivity to Amikacin (AMK; 100%) followed by Azithromycin (AZM; 85.7%), and Clarithromycin (CLR; 85.7%). Out of a total of 16 patients, 12 (75%) had total success with medical therapy while 4 (25%) required surgical intervention.

Conclusion: This study is focused on rapid and reliable identification of NTM keratitis through PCR-based identification method to enable effective medical management. The antibiotic susceptibility testing of different subspecies of NTM further reduced the need for surgical intervention. The effective role of AMK either alone or in combination with macrolide antibiotics is also highlighted in this study. 


Atypical Mycobacterial Keratitis, M. Abscessus, ontuberculous Mycobacterial Keratitis, Polymerase Chain Reaction

1. Covert TC, Rodgers MR, Reyes AL, et al. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 1999; 65: 2492–6.

2. Huang SCM, Soong HK, Chang JS, et al. Non tuberculosis mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol 1996; 80: 962–8.

3. Lalitha P, Rathinam SR, Srinivasan M. Ocular infections due to non-tuberculous mycobacteria. Indian J Med Microbiol 2004; 22: 231–7.

4. Hall-Stoodley L, Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS microbiology letters. 1998;168(1):77-84.

5. Turner L, Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol 1965; 60:329-31.

6. Moorthy RS, Valluri S, Rao NA. Nontuberculous mycobacterial ocular and adnexal infections. Surv Ophthalmol 2012; 57: 202–25.

7. Telenti A, Marchesi F, Balz M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction analysis. J Clin Microbiol. 1993; 31:175–178.

8. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959; 43: 273–90.

9. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American journal of respiratory and critical care medicine. 2007;175(4):367-416.

10. Girgis DO, Karp CL, Miller D. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clinical & experimental ophthalmology. 2012;40(5):467-75.

11. Kheir WJ, Sheheitli H, Abdul Fattah M, et al. Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature. Biomed Research International. 2015; 2015.

12. Ford JG, Huang AJ, Pflugfelder SC et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 1998; 105: 1652–8.

13. Chang MA, Jain S, Azar DT. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol 2004; 49:269 – 80.

14. Llovet F, de Rojas V, Interlandi E, et al. Infectious keratitis in 204 586 LASIK procedures. Ophthalmology. 2010;117(2):232-8.e84

15. Palani D, Kulandai LT, Naraharirao MH, et al. Application of polymerase chain reaction-based restriction fragment length polymorphism in typing ocular rapid- growing nontuberculous mycobacterial isolates from three patients with postoperative endophthalmitis. Cornea. 2007;26(6):729-35.

16. Chimara, E., Ferrazoli, L., Ueky, S.Y.M. et al. Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65patterns. BMC Microbiol 8, 48 (2008).

17. Srinivasan M, Prajana L, Prajana V. A cluster of cases of Mycobacterium chelonae keratitis following penetrating keratoplasty. Indian J Ophthalmol. 2005; 53:67–68.

18. Freitas D, Alvarenga L, Sampaio J et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003; 110: 276–85.

19. Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ Jr. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. Cornea. 2012;31(8):900-906.

20. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009; 53:1367–1376.

21. Reddy AK, Garg P, Babu KH, et al. In vitro antibiotic susceptibility of rapidly growing non- tuberculous mycobacteria isolated from patients with microbial keratitis. Curr Eye Res 2010; 35: 225–229.

22. Hamam RN, Nouredin B, Salti HI et al. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. Ophthalmology 2006; 113: 950–4.

23. de la Cruz J, Behlau I, Pineda R. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy. J Cataract Refract Surg 2007; 33: 1318–21.

24. Moshirfar M, Meyer JJ, Espandar L. Fourth- generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2007; 33: 1978–81.

25. Kuehne J, Yu ALT, Holland GN, et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol 2004; 138:547– 553.